216
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Value of Immunocytochemical Staining for the HPV E7 Protein in the Diagnosis of Cervical Lesions

, , , &
Pages 1081-1089 | Received 26 Dec 2022, Accepted 10 Mar 2023, Published online: 24 Mar 2023

References

  • Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8:e191–e203. doi:10.1016/S2214-109X(19)30482-6
  • Ronco G, Dillner J, Elfström KM, et al. Efficacy of HPV‑based screening for prevention of invasive cervical cancer: follow‑up of four European randomized controlled trials. Lancet. 2014;383(9916):524‑532. doi:10.1016/S0140-6736(13)62218-7
  • Huh WK, Ault KA, Chelmow D, et al. Use of primary high‑risk human papillomavirus testing for cervical cancer screening: interimclinical guidance. Gynecol Oncol. 2015;136(2):178‑182. doi:10.1016/j.ygyno.2014.12.022
  • Yamato K, Yamada T, Kizaki M, et al. New highly potent and specific E6 and E7 siRNAs for treatment of HPV 16 positive cervical cancer. Cancer Gene Ther. 2008;15:140–153. doi:10.1038/sj.cgt.7701118
  • Phelps WC, Yee CL, Münger K, Howley PM. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell. 1988;53:539–547. doi:10.1016/0092-8674(88)90570-3
  • Barbosa MS, Edmonds C, Fisher C, Schiller JT, Lowy DR, Vousden KH. The region of the HPV E7 oncoprotein homologous to adenovirus E1a and SV40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation. EMBO J. 1990;9:153–160. doi:10.1002/j.1460-2075.1990.tb08091.x
  • Ohlenschlager O, Seiboth T, Zengerling H, et al. Solution structure of the partially folded high-risk human papilloma virus 45 oncoprotein E7. Oncogene. 2006;25:5953–5959. doi:10.1038/sj.onc.1209584
  • Boyer SN, Wazer DE, Band V. E7 protein of human Papillomavirus16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res. 1996;56:4620–4624.
  • McLaughlin-Drubin ME, Park D, Munger K. Tumour suppressor p16 INK4A is necessary for survival of cervical carcinoma cell lines. Proc Natl Acad Sci USA. 2013;110:16175–16180. doi:10.1073/pnas.1310432110
  • Egawa N, Egawa K, Griffin H, et al. Human Papillomaviruses, epithelial tropisms, and the Development of Neoplasia Viruses. Viruses. 2015;7(7):3863–3890. doi:10.3390/v7072802
  • Shi WJ, Liu H, Wu D, et al. E6/E7 proteins are potential markers for the screening and diagnosis of cervical pre‑cancerous lesions and cervical cancer in a Chinese population. Oncol Lett. 2017;14:6251–6258. doi:10.3892/ol.2017.6932
  • Belinson JL, Pretorius RG. A standard protocol for the colposcopy exam. J Low Genit Tract Dis. 2016;20(4):e61‑62. doi:10.1097/LGT.0000000000000239
  • Jansen E, Zielonke N, Gini A, et al. Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review. Eur J Cancer. 2020;127:207‑223. doi:10.1016/j.ejca.2019.12.013
  • Rezhake R, Qiao YL, Zhao FH. Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women. Int J Cancer. 2019;144:34–42. doi:10.1002/ijc.31633
  • Shi L, Han F, Shi C, Huang Y, Liu Y, Chang X. Immunohistochemical detection of E7 human papillomavirus protein in pre-malignant and malignant lesions of uterine cervix. Mol Med Rep. 2018;18:3949–3956. doi:10.3892/mmr.2018.9416
  • Ghittoni R, Accardi R, Hasan U, et al. The biological properties of E6 and E7 oncoproteins from human papillomaviruses. Virus Genes. 2010;40(1):1–13. doi:10.1007/s11262-009-0412-8
  • Qiao YL, Jeronimo J, Zhao FH, et al. Lower cost strategies for triage of human papillomavirus DNA-positive women. Int J Cancer. 2014;134(12):2891–2901. doi:10.1002/ijc.28616